Prediction and prevention of type 1 diabetes

M Primavera, C Giannini, F Chiarelli - Frontiers in endocrinology, 2020 - frontiersin.org
Type 1 Diabetes (T1D) is one of the most common chronic autoimmune diseases in children.
The disease is characterized by the destruction of beta cells, leading to hyperglycemia, and …

The impact of type 2 diabetes on bone metabolism

CP Sanches, AGD Vianna, FC Barreto - Diabetology & Metabolic …, 2017 - Springer
Diabetes complications and osteoporotic fractures are two of the most important causes of
morbidity and mortality in older patients and share many features including genetic …

Identification of unique cell type responses in pancreatic islets to stress

MM Maestas, M Ishahak, P Augsornworawat… - Nature …, 2024 - nature.com
Diabetes involves the death or dysfunction of pancreatic β-cells. Analysis of bulk sequencing
from human samples and studies using in vitro and in vivo models suggest that endoplasmic …

Serum biomarkers for diagnosis and prediction of type 1 diabetes

L Yi, AC Swensen, WJ Qian - Translational Research, 2018 - Elsevier
Type 1 diabetes (T1D) culminates in the autoimmune destruction of the pancreatic βcells,
leading to insufficient production of insulin and development of hyperglycemia. Serum …

The alliance of mesenchymal stem cells, bone, and diabetes

N Napoli, R Strollo, A Paladini… - International Journal …, 2014 - Wiley Online Library
Bone fragility has emerged as a new complication of diabetes. Several mechanisms in
diabetes may influence bone homeostasis by impairing the action between osteoblasts …

[HTML][HTML] Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases

BJ Ryan, A Nissim, PG Winyard - Redox biology, 2014 - Elsevier
Tissue inflammation results in the production of numerous reactive oxygen, nitrogen and
chlorine species, in addition to the products of lipid and sugar oxidation. Some of these …

Combination immunotherapies for type 1 diabetes mellitus

P Pozzilli, E Maddaloni, R Buzzetti - Nature Reviews Endocrinology, 2015 - nature.com
Immunotherapies for type 1 diabetes mellitus (T1DM) have been the focus of intense basic
and clinical research over the past few decades. Restoring β-cell function is the ultimate …

Antibodies to post-translationally modified insulin in type 1 diabetes

R Strollo, C Vinci, MH Arshad, D Perrett, C Tiberti… - Diabetologia, 2015 - Springer
Aim/hypothesis Insulin is the most specific beta cell antigen and a potential primary
autoantigen in type 1 diabetes. Insulin autoantibodies (IAAs) are the earliest marker of beta …

[HTML][HTML] A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes

BO Roep, MJL Kracht, M van Lummel… - Current opinion in …, 2016 - Elsevier
Highlights•Beta cells communicate with other endocrine cells and immune cells during the
course of T1D.•Beta cells contribute to their own demise by generating neoantigens targeted …

Serum sclerostin and bone turnover in latent autoimmune diabetes in adults

N Napoli, R Strollo, G Defeudis, G Leto… - The Journal of …, 2018 - academic.oup.com
Purpose Bone formation is impaired in both type 1 diabetes and type 2 diabetes (T2D),
whereas sclerostin, an antagonist of bone formation, is increased in T2D only. No data are …